Correlation of Toll-Like Receptor 4, Interleukin-18, Transaminases, and Uric Acid in Patients With Chronic Periodontitis and Healthy Adults

被引:72
作者
Banu, Shaheena [1 ]
Jabir, Nasimudeen R. [2 ]
Mohan, Rekha [3 ]
Manjunath, Nanjappa C. [1 ]
Kamal, Mohammad Amjad [2 ]
Kumar, Kopparam Rajendra Vinod [3 ]
Zaidi, Syed Kashif [4 ]
Khan, Mohd Shahnawaz [5 ]
Tabrez, Shams [2 ]
机构
[1] Sri Jayadeva Inst Cardiovasc Sci & Res, Dept Biochem, Bangalore, Karnataka, India
[2] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia
[3] AECS Maaruti Coll Dent Sci & Res Ctr, Dept Periodontol, Bangalore, Karnataka, India
[4] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21589, Saudi Arabia
[5] King Saud Univ, Coll Sci, Dept Biochem, Prot Res Chair, Riyadh 11451, Saudi Arabia
关键词
Enzyme-linked immunosorbent assay; interleukin-18; periodontitis; Toll-like receptor 4; transaminases; uric acid; INFLAMMATORY RESPONSE; DISEASE; CELLS; MARKERS; LIPOPOLYSACCHARIDE; ASSOCIATION; ACTIVATION; EXPRESSION; INFECTION; CYTOKINES;
D O I
10.1902/jop.2014.140414
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Because of the potential association between periodontal disease and inflammation, the purpose of the present study is to examine the level of Toll-like receptor 4 (TLR-4), interleukin-18 (IL-18), and uric acid as markers of the inflammatory host response in the plasma and saliva of healthy individuals and patients with periodontitis. In addition, routine biochemical parameters such as fasting glucose, insulin, total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides, alanine transaminase (ALT), and aspartate transaminase (AST) were measured. The authors also wanted to check whether patients with chronic periodontitis (CP) exhibit different modulations in salivary and/or plasma concentrations of these parameters compared with clinically healthy individuals. Methods: Saliva and plasma samples were collected from 40 patients with CP and 20 healthy individuals. TLR-4 and IL-18 measurements were done using commercially available enzyme-linked immunosorbent assay kits. Total, HDL, and LDL cholesterol; triglycerides; fasting glucose; AST; and ALT levels were analyzed on a biochemistry analysis system using specific kits. Non-parametric tests were used for certain parameters in the statistical analyses because the data did not follow Gaussian distribution. Results: Significant differences were observed in plasma and salivary TLR-4 and IL-18 levels, along with clinical measurements such as plaque index and probing depth, in patients with CP (P <0.001). The plasma level of TLR-4 was found to be increased from 0.99 to 3.28 ng/mL in patients with CP. Salivary TLR-4 levels also showed a slightly higher increase in the diseased state (12.44 to 29.97 ng/mL). A significant increase of approximate to 46% was recorded in the plasma IL-18 level. However, salivary IL-18 levels rose up to >5-fold in the patients with CP compared with healthy individuals. The level of plasma uric acid was found to be highly significantly increased compared with control individuals. HDL cholesterol and triglyceride also showed significant differences (P <0.02 and P <0.03, respectively). Plasma glucose, total cholesterol, LDL cholesterol, and insulin levels did not show any significant difference. There was only a slight increase in plasma AST and ALT levels between diseased and healthy states (22.55 versus 25.50 IU/L and 12.35 versus 15.95 IU/L, respectively). However, salivary AST and ALT levels showed a approximate to 6-fold rise in the patients with CP compared with the healthy individuals. Cross-correlation analysis in the periodontitis disease group showed a significant association of plasma AST, salivary AST, and salivary ALT with uric acid level. Conclusions: Based on this study, the authors believe that TLR-4, IL-18, and uric acid could have a role in the inflammatory pathology of periodontitis. These parameters are suggested to be useful in the prognosis and diagnosis of CP. However, the mechanistic association of these parameters with inflammatory pathology of patients with periodontitis needs to be further elucidated in a higher number of samples.
引用
收藏
页码:431 / 439
页数:9
相关论文
共 50 条
[31]   Interleukin 18 and periodontal disease [J].
Orozco, A. ;
Gemmell, E. ;
Bickel, M. ;
Seymour, G. J. .
JOURNAL OF DENTAL RESEARCH, 2007, 86 (07) :586-593
[32]   Interleukin-17 and interleukin-18 levels in saliva and plasma of patients with chronic periodontitis [J].
Ozcaka, O. ;
Nalbantsoy, A. ;
Buduneli, N. .
JOURNAL OF PERIODONTAL RESEARCH, 2011, 46 (05) :592-598
[33]  
Papapanou P N, 1996, Ann Periodontol, V1, P1, DOI 10.1902/annals.1996.1.1.1
[34]   Periodontitis decreases the antiatherogenic potency of high density lipoprotein [J].
Pussinen, PJ ;
Jauhiainen, M ;
Vilkuna-Rautiainen, T ;
Sundvall, J ;
Vesanen, M ;
Palosuo, T ;
Alfthan, G ;
Asikainen, S .
JOURNAL OF LIPID RESEARCH, 2004, 45 (01) :139-147
[35]  
Reina S., 2013, ORAL BIOL DENT, V1, P3, DOI [10.7243/2053-5775-1-3, DOI 10.7243/2053-5775-1-3]
[36]   Innate immunity conferred by toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation [J].
Ru, LB ;
Scott, P ;
Sydlaske, A ;
Rose, DM ;
Terkeltaub, R .
ARTHRITIS AND RHEUMATISM, 2005, 52 (09) :2936-2946
[37]  
Sarah S M, 2006, Indian J Dent Res, V17, P114
[38]   How Do Periodontal Infections Affect the Onset and Progression of Alzheimer's Disease? [J].
Shaik, Munvar M. ;
Ahmad, Sultan ;
Gan, Siew H. ;
Abuzenadah, Adel M. ;
Ahmad, Ejaz ;
Tabrez, Shams ;
Ahmed, Farid ;
Kamal, Mohammad A. .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (03) :460-466
[39]   Molecular identification of a danger signal that alerts the immune system to dying cells [J].
Shi, Y ;
Evans, JE ;
Rock, KL .
NATURE, 2003, 425 (6957) :516-521
[40]   Cutting edge: Elimination of an endogenous adjuvant reduces the activation of CD8 T lymphocytes to transplanted cells and in an autoimmune diabetes model [J].
Shi, Yan ;
Galusha, Shelly A. ;
Rock, Kenneth L. .
JOURNAL OF IMMUNOLOGY, 2006, 176 (07) :3905-3908